Analysis Medical Supply International USA, Inc. (MSIU)
5/28/2024
Analysis of Medical Supply International USA, Inc. (MSIU)
Medical Supply International USA, Inc. (MSIU) seems to be trading at a consistent price of 0.00020. The Relative Strength Index (RSI) indicator, Moving Average Convergence Divergence (MACD) indicator, and Moving Averages (MA) indicators are all showing values of 0.00000, indicating a lack of significant movement or trend in the stock price.It's important to note that without any significant changes in these indicators, it may be challenging to identify potential trading opportunities or trends in the stock. Further analysis and monitoring of MSIU's price movements and key indicators may be necessary to make informed investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the transfer agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not supplied at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:1. Financials:
- Cash Flow: Operating cash flow (TTM) is $110,563,000,320 and levered free cash flow (TTM) is $84,726,874,112.
- Balance Sheet: Total cash (MRQ) is $67,150,000,128, total debt (MRQ) is $104,590,000,128, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue (TTM) is $381,623,009,280, diluted EPS (TTM) is $6.44, gross profit (TTM) is $169,148,000,000, revenue per share (TTM) is $24.537, net income to common (TTM) is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets (TTM): 22.073%
- Return on Equity (TTM): 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213
- Forward P/E: 26.213
- Trailing P/E: 29.429
- Enterprise Value: $2,948,462,018,560
- Price to Book (MRQ): 39.181
- Price to Sales (TTM): 7.615
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.53%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.51%
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a steady increase in revenue from 2020 to 2022, with a significant jump between 2021 and 2022.
2. However, in 2023, there was a slight decrease in revenue compared to the previous year.
3. Overall, the company has shown growth in revenue over the past four years, with some fluctuations in the most recent year.
These revenue figures provide insights into the company's performance and can be used to analyze its financial health and market position.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuuance.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, but generally, the company has maintained a healthy cash reserve.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been paying dividends consistently, with varying amounts each year.
9. The company has engaged in acquisitions and divestitures, impacting the investing cash flow.
10. Overall, the company's financial performance seems stable, with some fluctuations in specific activities.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share both for the upcoming quarters and the next year compared to the previous year's performance. It indicates growth and improvement in the company's financial performance as projected by analysts.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- In the past 5 years, the company has achieved an average annual growth rate of 20.15%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly higher growth rate projected for the next 5 years compared to the historical performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the average and median both indicating a price higher than the current price. The low end of the forecast suggests a potential decrease in price, while the high end indicates a significant increase. It's important to consider these different perspectives when making investment decisions.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $290,437,000,000 in 2023.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
MACD of MSIU
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
